Canopy Growth Corporation (WEED.TO)
CAD 4.07
(-7.08%)
CAD 4.07
(-7.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 77.29 Million CAD | -48.09% |
| 2022 | 148.9 Million CAD | -27.15% |
| 2021 | 204.38 Million CAD | -44.46% |
| 2020 | 367.97 Million CAD | -5.91% |
| 2019 | 391.08 Million CAD | 49.21% |
| 2018 | 262.1 Million CAD | 157.96% |
| 2017 | 101.6 Million CAD | 120.98% |
| 2016 | 45.98 Million CAD | 107.56% |
| 2015 | 22.15 Million CAD | 1895.64% |
| 2014 | 1.11 Million CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 84.51 Million CAD | 9.35% |
| 2023 Q3 | 86.91 Million CAD | -0.63% |
| 2023 Q4 | 77.29 Million CAD | -11.07% |
| 2023 FY | 77.29 Million CAD | -48.09% |
| 2023 Q1 | 142.06 Million CAD | -4.59% |
| 2023 Q2 | 87.47 Million CAD | -38.43% |
| 2022 Q1 | 205.51 Million CAD | 0.55% |
| 2022 Q2 | 211.2 Million CAD | 2.77% |
| 2022 Q3 | 213.93 Million CAD | 1.29% |
| 2022 FY | 148.9 Million CAD | -27.15% |
| 2022 Q4 | 148.9 Million CAD | -30.4% |
| 2021 Q3 | 365.75 Million CAD | 3.52% |
| 2021 FY | 204.38 Million CAD | -44.46% |
| 2021 Q4 | 204.38 Million CAD | -44.12% |
| 2021 Q2 | 353.3 Million CAD | -14.18% |
| 2021 Q1 | 411.67 Million CAD | 11.87% |
| 2020 Q1 | 389.8 Million CAD | -0.33% |
| 2020 Q2 | 398.45 Million CAD | 2.22% |
| 2020 Q3 | 394.02 Million CAD | -1.11% |
| 2020 FY | 367.97 Million CAD | -5.91% |
| 2020 Q4 | 367.97 Million CAD | -6.61% |
| 2019 Q2 | 461.75 Million CAD | 17.28% |
| 2019 Q4 | 391.08 Million CAD | -37.18% |
| 2019 Q3 | 622.57 Million CAD | 34.83% |
| 2019 Q1 | 393.73 Million CAD | 50.22% |
| 2019 FY | 391.08 Million CAD | 49.21% |
| 2018 Q2 | 150.4 Million CAD | 27.24% |
| 2018 FY | 262.1 Million CAD | 157.96% |
| 2018 Q4 | 262.1 Million CAD | 41.71% |
| 2018 Q3 | 184.96 Million CAD | 22.97% |
| 2018 Q1 | 118.2 Million CAD | 16.33% |
| 2017 FY | 101.6 Million CAD | 120.98% |
| 2017 Q4 | 101.6 Million CAD | 8.97% |
| 2017 Q3 | 93.24 Million CAD | 26.4% |
| 2017 Q2 | 73.76 Million CAD | 12.64% |
| 2017 Q1 | 65.48 Million CAD | 42.42% |
| 2016 Q3 | 50.59 Million CAD | 83.47% |
| 2016 FY | 45.98 Million CAD | 107.56% |
| 2016 Q2 | 27.57 Million CAD | 13.79% |
| 2016 Q4 | 45.98 Million CAD | -9.12% |
| 2016 Q1 | 24.23 Million CAD | 9.41% |
| 2015 Q3 | 22.8 Million CAD | 61.68% |
| 2015 Q4 | 22.15 Million CAD | -2.87% |
| 2015 FY | 22.15 Million CAD | 1895.64% |
| 2015 Q1 | 7.57 Million CAD | 18.62% |
| 2015 Q2 | 14.1 Million CAD | 86.32% |
| 2014 Q2 | 652.51 Thousand CAD | -45.73% |
| 2014 Q4 | 6.38 Million CAD | 475.01% |
| 2014 Q3 | 1.11 Million CAD | 70.12% |
| 2014 Q1 | 1.2 Million CAD | 1679.94% |
| 2014 FY | 1.11 Million CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | 67.55 Thousand CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | 58.529% |
| Avicanna Inc. | 4.54 Million CAD | -1600.879% |
| Avant Brands Inc. | 28.93 Million CAD | -167.104% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 27716.911% |
| Crescita Therapeutics Inc. | 6.12 Million CAD | -1161.91% |
| Knight Therapeutics Inc. | 91.83 Million CAD | 15.835% |
| MediPharm Labs Corp. | 9.89 Million CAD | -680.806% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | 4.522% |
| Willow Biosciences Inc. | 221 Thousand CAD | -34873.756% |
| Auxly Cannabis Group Inc. | 31.42 Million CAD | -145.926% |